Stocks

Belite Bio Inc ADR

BLTENASDAQUSDHealthcare

About Belite Bio Inc ADR

Belite Bio, Inc, a clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics with unmet medical needs in the United States. Its lead product candidate is Tinlarebant (LBS-008), an orally administered, which is in phase 3 clinical trial as an early intervention for maintaining the health and integrity of retinal tissues in stargardt disease type 1 and geographic atrophy patients. The company also develops LBS-009, an retinol binding protein 4 oral therapy, which is in preclinical development targeting liver disease, including non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, and type 2 diabetes, as well as gout. Belite Bio, Inc was founded in 2016 and is based in San Diego, California. Belite Bio, Inc operates as a subsidiary of Lin Bioscience International Ltd.

Ticker
BLTE
Trading on
NASDAQ
ISIN
-
Industry
Biotechnology
Sector
Healthcare
CEO
Dr. Yu-Hsin Lin M.B.A., Ph.D.
Headquarters
12750 High Bluff Drive, San Diego, CA, United States, 92130
Employees
41
Website
belitebio.com

Metrics

Market cap$6.62B
P/E ratio-
EPS-$2.84
Dividend Yield0.00%
Beta-1.19
Forward P/E ratio416.67
EBIDTA$-118M
Ex dividend date-

Analyst Insights & forecasts

Buy100%
Hold0%
Sell0%

Based on information from 9 analysts.

Average price target$233.00

Earnings per share (EPS) forecast

Q4 • 25Q1 • 26Q2 • 26
Actual-$0.70-$0.68-$0.70
Expected-$0.54-$0.64-$0.73
Surprise-29.63%-6.25%4.11%
MissedMissedCurrent

Financial Performance

Q2 • 26Q3 • 26QoQ growth
Revenue$0M$0MNaN%
Net income$-28.4M$-30.3M6.55%
Profit margin-∞%-∞%NaN%

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

FAQs

01How much is a Belite Bio Inc ADR share?

Belite Bio Inc ADR shares are currently traded for undefined per share.

02How many shares does Belite Bio Inc ADR have?

Belite Bio Inc ADR currently has 40.3M shares.

03Does Belite Bio Inc ADR pay dividends?

No, Belite Bio Inc ADR doesn't pay dividends.

04What is Belite Bio Inc ADR 52 week high?

Belite Bio Inc ADR 52 week high is $200.00.

05What is Belite Bio Inc ADR 52 week low?

Belite Bio Inc ADR 52 week low is $105.88.

06What is the 200-day moving average of Belite Bio Inc ADR?

Belite Bio Inc ADR 200-day moving average is $160.11.

07Who is Belite Bio Inc ADR CEO?

The CEO of Belite Bio Inc ADR is Dr. Yu-Hsin Lin M.B.A., Ph.D..

08How many employees Belite Bio Inc ADR has?

Belite Bio Inc ADR has 41 employees.

09What is the market cap of Belite Bio Inc ADR?

The market cap of Belite Bio Inc ADR is $6.62B.

10What is the P/E of Belite Bio Inc ADR?

The current P/E of Belite Bio Inc ADR is null.

11What is the EPS of Belite Bio Inc ADR?

The EPS of Belite Bio Inc ADR is -$2.84.

12What is the PEG Ratio of Belite Bio Inc ADR?

The PEG Ratio of Belite Bio Inc ADR is null.

13What do analysts say about Belite Bio Inc ADR?

According to the analysts Belite Bio Inc ADR is considered a buy.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.